Alex Thurman
Financieel Directeur/CFO bij GLAUKOS CORPORATION
Vermogen: 5 M $ op 30-04-2024
Actieve functies van Alex Thurman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GLAUKOS CORPORATION | Financieel Directeur/CFO | 01-04-2022 | - |
Hoofd Administratief Officier | 01-07-2016 | 01-12-2016 | |
Comptroller/Controller/Auditor | 01-07-2016 | 01-12-2016 | |
Corporate Officer/Principal | 01-12-2016 | 01-04-2022 | |
ALLERGAN PLC | Financieel Directeur/CFO | 01-12-2016 | - |
Loopbaan van Alex Thurman
Opleiding van Alex Thurman
Brigham Young University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Ierland | 2 |
Operationeel
Director of Finance/CFO | 2 |
Chief Administrative Officer | 1 |
Comptroller/Controller/Auditor | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GLAUKOS CORPORATION | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Beurs
- Insiders
- Alex Thurman
- Ervaring